These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 23012794

  • 1. [Physiology of novel AT1 receptor-binding molecule, ATRAP].
    Wakui H, Tamura K.
    Nihon Rinsho; 2012 Sep; 70(9):1499-503. PubMed ID: 23012794
    [Abstract] [Full Text] [Related]

  • 2. The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
    Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A, Umemura S.
    Curr Pharm Des; 2013 Sep; 19(17):3043-8. PubMed ID: 23176217
    [Abstract] [Full Text] [Related]

  • 3. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
    Wakui H.
    Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
    [Abstract] [Full Text] [Related]

  • 4. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T, Tamura K, Wakui H, Maeda A, Ohsawa M, Kanaoka T, Haku S, Kengo A, Masuda S, Shigenaga A, Azuma K, Matsuda M, Yabana M, Hirose T, Uchino K, Kimura K, Nagashima Y, Umemura S.
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [Abstract] [Full Text] [Related]

  • 5. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
    Wakui H, Tamura K, Matsuda M, Bai Y, Dejima T, Shigenaga A, Masuda S, Azuma K, Maeda A, Hirose T, Ishigami T, Toya Y, Yabana M, Minamisawa S, Umemura S.
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F991-F1003. PubMed ID: 20739392
    [Abstract] [Full Text] [Related]

  • 6. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.
    Tanaka Y, Tamura K, Koide Y, Sakai M, Tsurumi Y, Noda Y, Umemura M, Ishigami T, Uchino K, Kimura K, Horiuchi M, Umemura S.
    FEBS Lett; 2005 Mar 14; 579(7):1579-86. PubMed ID: 15757644
    [Abstract] [Full Text] [Related]

  • 7. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
    Azuma K, Tamura K, Shigenaga A, Wakui H, Masuda S, Tsurumi-Ikeya Y, Tanaka Y, Sakai M, Matsuda M, Hashimoto T, Ishigami T, Lopez-Ilasaca M, Umemura S.
    Hypertension; 2007 Nov 14; 50(5):926-32. PubMed ID: 17875818
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II Type 1 Receptor Binding Molecule ATRAP as a Possible Modulator of Renal Sodium Handling and Blood Pressure in Pathophysiology.
    Tamura K, Wakui H, Azushima K, Uneda K, Haku S, Kobayashi R, Ohki K, Haruhara K, Kinguchi S, Matsuda M, Yamashita A, Umemura S.
    Curr Med Chem; 2015 Nov 14; 22(28):3210-6. PubMed ID: 26295465
    [Abstract] [Full Text] [Related]

  • 9. ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth.
    Cui T, Nakagami H, Iwai M, Takeda Y, Shiuchi T, Tamura K, Daviet L, Horiuchi M.
    Biochem Biophys Res Commun; 2000 Dec 29; 279(3):938-41. PubMed ID: 11162453
    [Abstract] [Full Text] [Related]

  • 10. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules.
    Tsurumi Y, Tamura K, Tanaka Y, Koide Y, Sakai M, Yabana M, Noda Y, Hashimoto T, Kihara M, Hirawa N, Toya Y, Kiuchi Y, Iwai M, Horiuchi M, Umemura S.
    Kidney Int; 2006 Feb 29; 69(3):488-94. PubMed ID: 16514431
    [Abstract] [Full Text] [Related]

  • 11. Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule.
    Shigenaga A, Tamura K, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, Ozawa M, Mogi M, Matsuda M, Uchino K, Kimura K, Horiuchi M, Umemura S.
    Hypertension; 2008 Oct 29; 52(4):672-8. PubMed ID: 18725581
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ, Mogi M, Tamura K, Iwanami J, Sakata A, Fujita T, Tsukuda K, Jing F, Iwai M, Horiuchi M.
    J Mol Cell Cardiol; 2009 Dec 29; 47(6):798-809. PubMed ID: 19769983
    [Abstract] [Full Text] [Related]

  • 13. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
    Wakui H, Dejima T, Tamura K, Uneda K, Azuma K, Maeda A, Ohsawa M, Kanaoka T, Azushima K, Kobayashi R, Matsuda M, Yamashita A, Umemura S.
    Cardiovasc Res; 2013 Dec 01; 100(3):511-9. PubMed ID: 24189624
    [Abstract] [Full Text] [Related]

  • 14. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function.
    Tamura K, Tanaka Y, Tsurumi Y, Azuma K, Shigenaga A, Wakui H, Masuda S, Matsuda M.
    Curr Hypertens Rep; 2007 Apr 01; 9(2):121-7. PubMed ID: 17442223
    [Abstract] [Full Text] [Related]

  • 15. miR-125a-5p/miR-125b-5p contributes to pathological activation of angiotensin II-AT1R in mouse distal convoluted tubule cells by the suppression of Atrap.
    Hirota K, Yamashita A, Abe E, Yamaji T, Azushima K, Tanaka S, Taguchi S, Tsukamoto S, Wakui H, Tamura K.
    J Biol Chem; 2023 Dec 01; 299(12):105478. PubMed ID: 37981211
    [Abstract] [Full Text] [Related]

  • 16. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.
    Tamura K, Azushima K, Kinguchi S, Wakui H, Yamaji T.
    Hypertens Res; 2022 Jan 01; 45(1):32-39. PubMed ID: 34642449
    [Abstract] [Full Text] [Related]

  • 17. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy.
    Masuda S, Tamura K, Wakui H, Maeda A, Dejima T, Hirose T, Toyoda M, Azuma K, Ohsawa M, Kanaoka T, Yanagi M, Yoshida S, Mitsuhashi H, Matsuda M, Ishigami T, Toya Y, Suzuki D, Nagashima Y, Umemura S.
    Am J Physiol Renal Physiol; 2010 Oct 01; 299(4):F720-31. PubMed ID: 20685825
    [Abstract] [Full Text] [Related]

  • 18. Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
    Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Masuda S, Shigenaga A, Maeda A, Mogi M, Ichihara N, Kobayashi Y, Hirawa N, Ishigami T, Toya Y, Yabana M, Horiuchi M, Minamisawa S, Umemura S.
    Hypertension; 2010 May 01; 55(5):1157-64. PubMed ID: 20231526
    [Abstract] [Full Text] [Related]

  • 19. Renal tubule angiotensin II type 1 receptor-associated protein promotes natriuresis and inhibits salt-sensitive blood pressure elevation.
    Wakui H, Uneda K, Tamura K, Ohsawa M, Azushima K, Kobayashi R, Ohki K, Dejima T, Kanaoka T, Tsurumi-Ikeya Y, Matsuda M, Haruhara K, Nishiyama A, Yabana M, Fujikawa T, Yamashita A, Umemura S.
    J Am Heart Assoc; 2015 Mar 19; 4(3):e001594. PubMed ID: 25792129
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.
    Am J Hypertens; 2005 Apr 19; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.